欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/0491/001
药品名称Tamsulogen 0.4 mg
活性成分
    • Tamsulosin hydrochloride 0.4 mg
剂型Modified-release capsule, hard
上市许可持有人Viatris Limited Damastown Industrial Park, Mulhuddart Dublin 15 Ireland
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Germany (DE)
    • Belgium (BE)
      Tamsulosine Viatris 0,4 mg harde capsules met gereguleerde afgifte
    • Netherlands (NL)
      Tamsulosine HCl Retard Mylan 0,4 mg (RVG 32577)
    • Iceland (IS)
    • Ireland (IE)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Norway (NO)
    • Poland (PL)
      TAMSUGEN 0,4 tabletki o przedłużonym uwalnianiu
    • Czechia (CZ)
    • Slovakia (SK)
      Tamsulosin HCL Mylan 0,4 mg
    • United Kingdom (Northern Ireland) (XI)
许可日期2005/09/20
最近更新日期2024/10/24
药物ATC编码
    • G04CA02 tamsulosin
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Multiple (Copy) Application
  • TypeLevel3:Generic [Article 10.1.(a)(iii), first paragraph]
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase